AI-Assisted · Human-Edited · Publicly Tracked
The stocks no analyst
will touch.
Small-cap research on companies the sell side ignores. Every thesis gets a research ID and public reviews at 3, 6, and 12 months. Nothing gets deleted.
Recent Analysis
All posts →-
CRAI Stock Analysis 2026-08-22CRA International: The Expert Witness Economics Firm Hiding in Plain Sight
CRA International earns $752M annually advising courts and regulators through Ph.D. expert witnesses. A 'Consulting Services' screener label keeps the litigation economics franchise chronically under-covered at 2 Wall Street ratings on a $1.1B market cap.
-
BH Stock Analysis 2026-08-08Biglari Holdings (BH): When the Investment Portfolio Holds the Company's Own Stock
BH's -$67M pre-tax investment line reflects a real loss on the fund's third-party holdings. But BH's interests in the Lion Funds simultaneously had $150M in gains on BH's own stock that accounting eliminates—making the total portfolio up $83M while GAAP shows a loss.
-
JBSS Stock Analysis 2026-08-06John B. Sanfilippo & Son (JBSS): The Nut Company Analysts Stopped Watching
JBSS has generated $84–90M in operating income every year for five consecutive fiscal years on $1.1B in revenue. One to two analysts cover it. The reason is structural—but the valuation reflects it.